General Information
Revision date
2021-02-10
Product name
OTILIMAB INJECTION 90 MG/ML
Product Synonyms
OTILIMAB CONCENTRATE FOR SOLUTION FOR INFUSION 90 MG * OTILIMAB INJECTION 90
CAS No.
1638332-55-4
Icons in SDS
Company Information
company name
GlaxoSmithKline UK
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
None
Section 2
2.1 Classification of the substance or mixture
The mixture has been assessed and/or tested for its physical, health and environmental hazards and the following classification applies.
EU Classification
Regulation (EC) No 1272/2008 as amended This mixture does not meet the criteria for classification according to Regulation (EC) 1272/2008 as amended. Hazard summary Caution - Pharmaceutical agent. Direct contact with eyes may cause temporary irritation. See section 11 of the SDS for additional information on health hazards.
2.2 Label elements
Label according to Regulation (EC) No. 1272/2008 as amended
Contains
OTILIMAB
Hazard pictograms
None.
Signal word
None.
Hazard statements
The mixture does not meet the criteria for classification.
Prevention
Not available.
Response
Not available.
Storage
Not available.
Disposal
Not available.
Supplemental label elements
3,643 % of the mixture consists of component(s) of unknown acute oral toxicity. 12,643 % of the mixture consists of component(s) of unknown acute dermal toxicity. 9 % of the mixture consists of component(s) of unknown acute inhalation toxicity. 12,643 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 12,643 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
2.3 Other hazards
Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
